Zacks Small Cap Research on MSN

CRDF: Phase II update; survival advantage extended

By John Vandermosten, CFA NASDAQ: CRDF READ THE FULL CRDF RESEARCH REPORT Updated Results from CRDF-004 Cardiff Oncology, Inc ...
Tech Times

AI-Designed Universal Coronavirus Vaccine Passes First Human Trial: Cambridge Team Eyes Phase II

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...
GlobalData on MSN

Novo Nordisk reports Phase II data for zenagamtide in diabetes

The primary endpoint, change in HbA1C after 36 weeks, was met at all doses.

As the Ebola Epidemic Spreads, NV-387 Oral Gummies Can Enter a Phase II Clinical Trial for Treatment of Ebola – NanoViricides Proposal is Approved by the Pillar Committee in ...

SHELTON, CT / ACCESS Newswire / June 15, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...

Cynata Therapeutics Limited (CYYNF) Discusses Phase II Acute Graft Versus Host Disease and Phase III Osteoarthritis Trial Results Transcript

Discusses Phase II Acute Graft Versus Host Disease and Phase III Osteoarthritis Trial Results June 21, 2026 6:30 ...
Nature

Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial

The hedgehog pathway is implicated in resistance to anticancer therapies in glioblastoma (GB). GEINO1602 (NCT03466450) phase Ib/II study evaluated the safety and efficacy of glasdegib and the Stupp ...
ascopubs.org

Dual targeting of VEGF and PD-1: A phase I/II trial of ivonescimab, a novel bispecific antibody, in recurrent glioblastoma.

Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...